No mutual correlation was observed between mTOR (e.g. p-S6) and MAPK signalling (Fig. 2c, d), confirming that in the majority of breast cancer cells these signalling pathways are not significantly co-activated. The gene discussed is MTOR; the disease is breast cancer.